Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant BTLA anticorps

L’anticorps Lapin Chimeric anti-BTLA a été validé pour WB, FACS, IP, Func et BP. Il convient pour détecter BTLA dans des échantillons de Souris.
N° du produit ABIN7072472

Aperçu rapide pour Recombinant BTLA anticorps (ABIN7072472)

Antigène

Voir toutes BTLA Anticorps
BTLA (B and T Lymphocyte Associated (BTLA))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 79
  • 34
  • 2
  • 2
  • 1
  • 1
Souris

Hôte

  • 40
  • 40
  • 10
  • 4
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 57
  • 39
  • 1
Chimeric

Conjugué

  • 49
  • 6
  • 6
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BTLA est non-conjugé

Application

  • 51
  • 44
  • 30
  • 13
  • 13
  • 9
  • 8
  • 7
  • 6
  • 6
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunoprecipitation (IP), Functional Studies (Func), Blocking Peptide (BP)

Clone

HMBT-6B2
  • Fonction

    Anti-BTLA [HMBT-6B2], Rabbit IgG, kappa

    Specificité

    This antibody is specific for B and T lymphocyte attenuator (BTLA), which functions as a negative regulator of T cell activation and proliferation, and attenuates B cell proliferation upon associating with its known ligand, herpes virus entry mediator (HVEM).

    Attributs du produit

    Original Species of Ab: Hamster, Armenian

    Original Format of Ab: IgG

    Purification

    Protein A affinity purified

    Immunogène

    This antibody was raised by immunising Armenian hamsters with mouse BTLA:Fc fusion protein.

    Isotype

    IgG kappa
  • Indications d'application

    This antibody has been used in immunoblot analyses to confirm that B and T lymphocyte attenuator (BTLA) regulates T cell activation through interaction with herpesvirus entry mediator (HVEM) (Sedy et al, 2005), as well as in FACS and yeast display technology to demonstrate that BTLA exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T Cells (Hurchla et al, 2005). In a mouse conjunctivitis model, treatment with this antibody during the induction phase has been shown to decrease B-cell population, upregulate Th2 cytokine production and increase the conjunctival eosinophile numbers (Ishida et al, 2012). However, treatment with this antibody during the effector phase does not affect the development of experimental conjunctivitis (Ishida et al, 2012).

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    BTLA (B and T Lymphocyte Associated (BTLA))

    Autre désignation

    BTLA

    Sujet

    CD272, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, B and T lymphocyte associated protein, B- and T-lymphocyte-associated protein, BTLA1, FLJ16065, MGC129743

    UniProt

    Q7TSA3

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!